PRESSEMITTEILUNGEN

(pressebox) Martinsried/Munich, 26.08.2009, 4SC AG (Frankfurt, Prime Standard: VSC) the German drug discovery and development company, today announced it will present an update on the company’s strategy, programmes and prospects at the following investor conferences in August and September:

August 31 – CFO Enno Spillner presents at the Sal. Oppenheim European Healthcare Conference 2009, Frankfurt, Germany at 5.25pm local time.

September 9 – CEO Ulrich Dauer presents at Rodman and Renshaw Annual Global Investment Conference, New York, USA at 2.25pm local time.

September 11 – CDO Bernd Hentsch presents at the DZ Bank German Healthcare Conference, Zurich, Switzerland, at 3.05pm local time.

Legal Note

This document may contain projections or estimates relating to plans and objectives relating to our future operations, products, or services; future financial results; or assumptions underlying or relating to any such statements; each of which constitutes a forward-looking statement subject to risks and uncertainties, many of which are beyond our control. Actual results could differ materially, depending on a number of factors.
Diese Pressemitteilung beobachten

Gerne informieren wir Sie per E-Mail, sobald inaktive Pressemitteilungen vom Herausgeber freigeschaltet werden. Beobachten Sie dazu die entsprechenden Meldungen:

Trackback URL

Assumptions, August And September, Drug Discovery And Development, Dz Bank, E Mail, European Healthcare, Frankfurt Germany, Global Investment, Healthcare Conference, Investment Conference, Investor Conferences, Martinsried, New York Usa, Operations Products, Prime Standard, Renshaw, Rodman, Sal Oppenheim, September 9, Zurich Switzerland